Srb Corp Bio Rad Laboratories, Inc. Transaction History

Srb Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$463.67 - $597.16 $836,924 - $1.08 Million	-1,805 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $266,523 - $298,799	-376 Reduced 17.24%	1,805 $1.36 Million
Q3 2021 Nov 12, 2021	SELL	$657.71 - $825.77 $664,944 - $834,853	-1,011 Reduced 31.67%	2,181 $1.63 Million
Q2 2021 Aug 13, 2021	BUY	$576.64 - $649.04 $387,502 - $436,154	672 Added 26.67%	3,192 $2.06 Million
Q1 2021 May 14, 2021	BUY	$547.01 - $662.35 $649,300 - $786,209	1,187 Added 89.05%	2,520 $1.44 Million
Q4 2020 Feb 12, 2021	BUY	$510.68 - $643.45 $108,264 - $136,411	212 Added 18.91%	1,333 $777,000
Q3 2020 Nov 13, 2020	BUY	$454.43 - $535.6 $509,416 - $600,407	1,121 New	1,121 $577,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.38B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Srb Corp, based on Form 13F filings with the SEC.

Stay updated on Srb Corp with notifications on news.